Skip to Content
Print Save

R531 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint R531 is Pink, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R531

Divalproex sodium delayed-release 500 mg R531

Divalproex Sodium Delayed-Release

Imprint
R531
Strength
500 mg
Color
Pink
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC)
55111-0531
Inactive Ingredients
acetone, hypromellose, hypromellose phthalate (31% phthalate, 40 cst), isopropyl alcohol, methylene chloride, microcrystalline cellulose, povidone, corn starch, silicon dioxide, magnesium silicate, titanium dioxide, vanillin, shellac, ferrosoferric oxide, butyl alcohol, soya lecithin, ferric oxide red

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "R531"

Valrelease
Alprazolam
Tolinase

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer